About Mectizan

Press Releases

Merck Issues Statement on WHO Study Showing First Evidence that Elimination of River Blindness Is Feasible in Africa

World Bank and Merck & Co., Inc., Announce U.S. $50 Million Funding Initiative to Eliminate River Blindness in Africa

Public Health Officials Announce Progress in Elimination of Transmission Of the Tropical Disease River Blindness

Merck & Co., Inc. Renews Commitment to MECTIZAN® Donation Program Until Disease has been Eliminated as a Public Health Problem Globally

Merck & Co., Inc. and Drugs for Neglected Diseases initiative Collaborate to Find Treatments for World's Most Neglected Tropical Diseases

GSK giving figures exceed £300 million for fourth year running: medicines for Lymphatic Filariasis elimination valued at £16 million

Attachment	Size
Merck_IACO_press_release.pdf	21.9 KB
Mectizan Statement for WHO Release 7-20 430pm FINAL.pdf	21.49 KB

Website Design By
NRM Creative Marketing

325 Swanton Way, Decatur, Georgia 30030
Phone: +1.404.371.1460 | Fax: +1.404.371.1138
© 2009 Mectizan Donation Program | Login